Ranolazine and other antianginal therapies in the era of the drug-eluting stent

被引：5

作者：

Berger, P

机构：

[1] Duke Univ, Med Ctr, Duke Clin Res Inst, Dept Med,Div Cardiol, Durham, NC 27705 USA

[2] Duke Univ, Med Ctr, Div Cardiovasc Dis, Dept Med,Div Cardiol, Durham, NC 27705 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2004年 / 291卷 / 03期

关键词：

D O I：

10.1001/jama.291.3.365

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：365 / 367

页数：3

共 24 条

[11] Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention - REPLACE-2 Randomized Trial [J].

Lincoff, AM ;

Bittl, JA ;

Harrington, RA ;

Feit, F ;

Kleiman, NS ;

Jackman, JD ;

Sarembock, IJ ;

Cohen, DJ ;

Spriggs, D ;

Ebrahimi, R ;

Keren, G ;

Carr, J ;

Cohen, EA ;

Betriu, A ;

Desmet, W ;

Kereiakes, DJ ;

Rutsch, W ;

Wilcox, RG ;

de Feyter, PJ ;

Vahanian, A ;

Topol, EJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (07) :853-863

[12]

Madsen JK, 1997, CIRCULATION, V96, P748

[13] Percutaneous coronary intervention versus medical therapy for coronary heart disease. [J].

Maron D.J. .

Current Atherosclerosis Reports, 2000, 2 (4) :290-296

[14] Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery [J].

Moses, JW ;

Leon, MB ;

Popma, JJ ;

Fitzgerald, PJ ;

Holmes, DR ;

O'Shaughnessy, C ;

Caputo, RP ;

Kereiakes, DJ ;

Williams, DO ;

Teirstein, PS ;

Jaeger, JL ;

Kuntz, RE .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (14) :1315-1323

[15]

OROURKE RA, 1999, CURR PRACT MED, V2, P225

[16] Defining gene transfer before expecting gene therapy - Putting the horse before the cart [J].

Pislaru, S ;

Janssens, SP ;

Gersh, BJ ;

Simari, RD .

CIRCULATION, 2002, 106 (05) :631-636

[17] Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease [J].

Pitt, B ;

Waters, D ;

Brown, WV ;

van Boven, AJ ;

Schwartz, L ;

Title, LM ;

Eisenberg, D ;

Shurzinske, L ;

McCormick, LS .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (02) :70-76

[18] A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions [J].

Stone, GW ;

Teirstein, PS ;

Rubenstein, R ;

Schmidt, D ;

Whitlow, PL ;

Kosinski, EJ ;

Mishkel, G ;

Power, JA .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (10) :1581-1587

[19] Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. [J].

Topol, EJ ;

Moliterno, DJ ;

Herrmann, HC ;

Powers, ER ;

Grines, CL ;

Cohen, DJ ;

Cohen, EA ;

Bertrand, M ;

Neumann, FJ ;

Stone, GW ;

DiBattiste, PM ;

Demopoulos, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) :1888-1894

[20]

Wallentin L, 1999, LANCET, V354, P708

← 1 2 3 →